Alzheimers Disease
Jul 17, 2018
Neuroscience Highlights – 17/07/2018
Alkermes Gets FDA approval for Aristada Initio (aripiprazole lauroxil) as Part of Schizophrenia Treatment Combination Alkermes has announced that the U.S. FDA approved ARISTADA INITIO (aripiprazole lauroxil) for the initiation of ARISTADA (aripiprazole lauroxil), a long-acting injectable atypical antipsychotic f...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
